Table 4.
Multiivariate Cox regression analyses of the expression of miR-302b, EphA2 with the clinicopathologic characteristics in the training and validation cohorts.
| Variable | Comparison | Training set | Validation set | |||
|---|---|---|---|---|---|---|
| HR (95%CI) | P | HR (95%CI) | P | |||
| Liver metastasis | Yes vs. No | 1.11 (0.67 - 1.86) | 0.679 | 1.38 (0.86 - 2.21) | 0.185 | |
| Peritoneal metastasis | Yes vs. No | 1.97 (1.21 - 3.22) | 0.006 | 1.65 (1.07 - 2.54) | 0.024 | |
| EphA2 | High vs. Low | 2.84 (1.34 - 6.01) | 0.006 | 1.64 (1.06 - 2.54) | 0.028 | |
| miR302b | Low vs. High | 1.86 (1.11 - 3.14) | 0.021 | 1.51 (1.04 - 2.20) | 0.030 | |